BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210420
DTEND;VALUE=DATE:20210423
DTSTAMP:20260515T181356
CREATED:20201224T123305Z
LAST-MODIFIED:20201224T123305Z
UID:28380-1618876800-1619135999@www.pharmajournalist.com
SUMMARY:Anti-Infectives Drug Development – Digital Summit
DESCRIPTION:Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater\, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments\, biopharma\, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance. \nWith some now considering the field as the new ‘Wall Street darling’\, especially given the $1 billion launch of the AMR action fund\, the Digital Anti-Infectives Drug Development Summit has arrived as the most comprehensive and industry-dedicated forum that addresses the biggest challenges in the development and commercialization of anti-infective drugs. \n \nBringing together 60+ senior leaders from large pharma\, innovative biotech\, academia and investment companies\, join us this April to discuss data-driven and solution-based approaches that focus on developing high value clinical candidates\, novel modalities and effective strategies\, that address market sustainability and aim for superiority. \nWhat you can expect: \n\nReimagine anti-infective drug development to ensure economic sustainability\, with insight from Merck\, CARB-X & AlloVir\n\n\nExplore the non-traditional approaches employed to combat multi-drug resistance\, with insight from Locus Biosciences\, Peptilogics & SciBac\n\n\nAdvance the clinical superiority of anti-infectives to drive commercial success\, with insight from ContraFect & Summit Therapeutics\n\n\nTarget the unmet medical need to ensure drug development pipeline success\, with insight from BioVersys\, Entasis Therapeutics & Spero Therapeutics\n\n\nDiscover superior novel strategies to combat anti-microbial resistance\, with insight from Techulon\, MicuRX & Princeton University\n\nTo know more about Anti-Infectives Drug Development please click here.
URL:https://www.pharmajournalist.com/event/anti-infectives-drug-development-digital-summit/
LOCATION:Digital Event\, EDT
ORGANIZER;CN="Hansonwade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210422
DTEND;VALUE=DATE:20210424
DTSTAMP:20260515T181356
CREATED:20210301T101134Z
LAST-MODIFIED:20210301T101134Z
UID:29204-1619049600-1619222399@www.pharmajournalist.com
SUMMARY:4th Annual MarketsandMarkets Real-World Data\, Life Sciences Analytics and Market Access Virtual Conference (Time Zone - EST)
DESCRIPTION:MarketsandMarkets is proud to announce the 4th Annual MarketsandMarkets Real-World Data\, Life Sciences Analytics and Market Access Virtual Conference to be held on 22- 23 April\, 2021. \nWhile the 3rd annual virtual conference had discussions on how the insights derived from real world data\, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators\, doctors\, and payers\, the 4th Annual conference will focus on discussion about the application of RWD/RWE across the life cycle. The event will discuss Impact of COVID-19 on the real-world generation and making sense of the Electronic Health Records data for COVID-19. \nOur aim for the 4th Annual Virtual Conference is to unite all stakeholders in a virtual room to learn how to overcome the challenges caused due to the pandemic\, efficiently and effectively generating RWE for stakeholders including payers\, patients and physicians. \nEvent Website https://events.marketsandmarkets.com/4th-edition-marketsandmarkets-real-world-data-life-sciences-analytics-and-market-access-virtual-conference-uk-eu/ \nRegistration link:  https://events.marketsandmarkets.com/4th-edition-marketsandmarkets-real-world-data-life-sciences-analytics-and-market-access-virtual-conference-uk-eu/register 
URL:https://www.pharmajournalist.com/event/4th-annual-marketsandmarkets-real-world-data-life-sciences-analytics-and-market-access-virtual-conference-time-zone-est/
LOCATION:Virtual Event
ORGANIZER;CN="Marketsandmarkets":MAILTO:Shardul.oza@marketsandmarkets.com, events@marketsandmarkets.com
END:VEVENT
END:VCALENDAR